Compare ULH & CYRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ULH | CYRX |
|---|---|---|
| Founded | 1932 | 1999 |
| Country | United States | United States |
| Employees | N/A | 1100 |
| Industry | Trucking Freight/Courier Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 354.9M | 419.3M |
| IPO Year | 2004 | 2008 |
| Metric | ULH | CYRX |
|---|---|---|
| Price | $17.21 | $15.70 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 1 | 8 |
| Target Price | ★ $20.00 | $13.31 |
| AVG Volume (30 Days) | 61.4K | ★ 789.8K |
| Earning Date | 05-12-2026 | 05-04-2026 |
| Dividend Yield | ★ 1.74% | N/A |
| EPS Growth | N/A | ★ 156.22 |
| EPS | ★ N/A | N/A |
| Revenue | ★ $1,461,708,000.00 | $176,177,000.00 |
| Revenue This Year | $2.73 | $11.06 |
| Revenue Next Year | $5.12 | $8.45 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $11.73 | $6.33 |
| 52 Week High | $30.76 | $16.73 |
| Indicator | ULH | CYRX |
|---|---|---|
| Relative Strength Index (RSI) | 54.57 | 67.65 |
| Support Level | $14.82 | $7.98 |
| Resistance Level | $18.79 | N/A |
| Average True Range (ATR) | 0.96 | 0.66 |
| MACD | 0.57 | 0.07 |
| Stochastic Oscillator | 85.44 | 70.73 |
Universal Logistics Holdings Inc is an asset-light provider of customized transportation and logistics solutions throughout the United States, and in Mexico, Canada, and Colombia. It offers services such as truckload, brokerage, intermodal, dedicated, and value-added services. The firm has three reportable segments, namely contract logistics, intermodal, and trucking. The company generates the key revenue from Contract Logistics, which provides value-added and dedicated transportation services to support inbound and internal logistics requirements of industrial manufacturers and retailers, generally under contractual arrangements of one year or longer. Geographically, the firm generates the majority of its revenue from the United States, followed by Mexico, Canada, and Colombia.
CryoPort Inc is a provider of integrated, temperature-controlled supply chain solutions for the life sciences industry, with a focus on supporting the cell and gene therapy market. The company provides services such as temperature-controlled logistics, biostorage, bioservices, cryopreservation solutions, and cryogenic systems manufacturing. It operates through two reportable segments: Life Sciences Services and Life Sciences Products. It generates the majority of its revenue from the Life Sciences Services segment.